 Find out what's happening with your money. In fact, it's called Your Money Now. I'm Dom Savino with Your Money Now. Shares of two of the world's largest pharmaceutical companies are moving in opposite directions today. It's all because of a new data analysis showing Eli Lilly's popular obesity drug, Moonjaro, leads to faster and greater weight loss than Novo Nordisk's treatment, Wegovii.